Institutional investors purchased a net $1.8 million shares of OGEN during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 14.23% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.2 Million shares of Oragenics Inc
MSDC MANAGEMENT LP Bought 400.0 Thousand shares of Oragenics Inc
THE VANGUARD GROUP, INC. Bought 117.6 Thousand shares of Oragenics Inc